Unexplained pulmonary hypertension in chronic myeloproliferative disorders

Chest

Volumn 120, Issue 3, 2001, Pages 801-808

  Dingli, David ^a   Utz, James P ^a   Krowka, Michael J ^a   Oberg, Ann L ^a   Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

Author keywords

Essential thrombocythemia; Myelofibrosis with myeloid metaplasia; Myeloproliferative disorders; Polycythemia vera; Pulmonary hypertension

Indexed keywords

ANAGRELIDE; BUSULFAN; HEMOGLOBIN; HYDROXYUREA;

ADULT; AGED; ARTICLE; CARDIOPULMONARY ARREST; CAUSE OF DEATH; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART RIGHT VENTRICLE; HEMATOLOGIC DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; LUNG ARTERY PRESSURE; MALE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

EID: 0034832857     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.3.801     Document Type: Article

References (26)

1. The Philadelphia chromosome negative chronic myeloproliferative disorders: A practical overview
2. Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia
3. Pulmonary hypertension in polycythemia vera
4. Pulmonary hypertension associated with long-standing thrombocytosis
5. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases
6. The patient record in epidemiology
7. Myelofibrosis with myeloid metaplasia
8. Primary thrombocythemia
9. Primary pulmonary hypertension
10. Portopulmonary hypertension: The next step
11. The threat to medical-records research
12. Selection bias in the referral of patients and the natural history of surgical conditions
13. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted County study, 1976-1995
14. Molecular defects in chronic myeloproliferative disorders
15. Cardiac involvement in patients with myeloproliferative disorders
16. Tc-99m sulfur colloid demonstration of diffuse pulmonary interstitial extramedullary hematopoiesis and fibrosis in a patient with myelofibrosis: A case report and review of the literature
17. Myointimal hyperplasia: Basic science and and clinical considerations
18. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats
19. Metabolism of prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states
20. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome
21. Coexistent pulmonary and portal hypertension: Morphologic and clinical features
22. Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders
23. Lung damage from cytotoxic drugs
24. Anagrelide, a therapy for thrombocythemic states: Experience in 577 patients
25. Pulmonary hypertension after splenectomy?
26. Limitations of the application of fourfold table analysis to hospital data